Smith Mark Douglas
SEC CIK 1756253 · EDGAR
BoughtSold
Most active insiders at JAZZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COZADD BRUCE C | Dir | — | $27.15M |
| 2 | Iannone Robert | EVP, CMO, Gbl Head of R, D | — | $20.41M |
| 3 | Patil Neena M | EVP, CLO | — | $11.50M |
| 4 | Carr Patricia | SVP, CAO | — | $2.46M |
| 5 | Winningham Rick E | Dir | — | $1.66M |
| 6 | Pearce Samantha | EVP, Chief Commercial Off | — | $1.63M |
| 7 | Henderson Mary Elizabeth | SVP, Technical Ops | — | $1.42M |
| 8 | McSharry Heather Ann | Dir | — | $1.09M |
| 9 | RIEDEL NORBERT G | Dir | — | $655.7K |
| 10 | GALA RENEE D | Pres, CEO | — | $486.1K |
| 11 | Smith Mark Douglas | Dir | — | $266.7K |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-02 17:34 | 2026-08-31 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | F - Tax | $241.42 | -1,706 | 9,579 | -15% | -$411.9K |
| 2026-08-07 17:46 | 2026-08-05 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | A - Grant | $0.00 | +1,605 | 11.3K | +17% | $0 | |
| 2026-06-26 16:22 | 2026-06-24 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | A - Grant | $9.59 | +19.3K | 56.6K | +52% | +$185.0K | |
| T | 2026-06-17 16:45 | 2026-06-15 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | S - Sale | $230.55 | -1,157 | 9,680 | -11% | -$266.7K |
| 2025-08-11 | 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | A - Grant | $0.00 | +3,507 | 12.6K | +38% | $0 | |
| 2025-08-11 | 2025-08-08 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | F - Tax | $111.25 | -1,805 | 10.8K | -14% | -$200.8K | |
| D | 2025-07-03 | 2025-07-02 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | S - Sale+OE | $29.00 | -7,000 | 37.4K | -16% | -$203.0K |
| D | 2025-07-03 | 2025-07-02 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | M - OptEx | $4.71 | +7,000 | 44.4K | +19% | +$33.0K |
| 2025-06-27 | 2025-06-25 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | A - Grant | $27.61 | +6,700 | 37.4K | +22% | +$185.0K | |
| 2024-08-19 | 2024-08-15 | TDOC | Teladoc Health, Inc. | Smith Mark Douglas | Dir | P - Purchase | $7.08 | +4,000 | 8,355 | +92% | +$28.3K | |
| 2024-08-06 | 2024-08-06 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | F - Tax | $111.35 | -1,484 | 9,135 | -14% | -$165.2K | |
| 2024-08-06 | 2024-08-02 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | A - Grant | $0.00 | +3,731 | 10.6K | +54% | $0 | |
| D | 2024-07-22 | 2024-07-18 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | M - OptEx | $4.71 | +7,000 | 37.7K | +23% | +$33.0K |
| D | 2024-07-22 | 2024-07-18 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | S - Sale+OE | $25.00 | -7,000 | 30.7K | -19% | -$175.0K |
| 2024-06-28 | 2024-06-26 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | A - Grant | $0.00 | +8,490 | 30.7K | +38% | $0 | |
| 2023-12-06 | 2023-12-04 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | S - Sale | $119.27 | -417 | 6,888 | -6% | -$49.7K | |
| 2023-08-15 | 2023-08-14 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | S - Sale | $138.16 | -1,241 | 7,305 | -15% | -$171.5K | |
| 2023-08-15 | 2023-08-11 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | A - Grant | $0.00 | +3,075 | 8,546 | +56% | $0 | |
| 2023-06-30 | 2023-06-28 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | A - Grant | $0.00 | +6,051 | 22.2K | +38% | $0 | |
| DMT | 2023-04-05 | 2023-04-03 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | S - Sale+OE | $30.77 | -7,000 | 16.6K | -30% | -$215.4K |
| DT | 2023-04-05 | 2023-04-03 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | M - OptEx | $4.71 | +7,000 | 23.1K | +43% | +$33.0K |
| 2022-12-06 | 2022-12-02 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | S - Sale | $154.68 | -420 | 5,471 | -7% | -$65.0K | |
| 2022-08-09 | 2022-08-08 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | S - Sale | $152.32 | -1,089 | 5,891 | -16% | -$165.9K | |
| 2022-08-09 | 2022-08-05 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | A - Grant | $0.00 | +2,561 | 6,980 | +58% | $0 | |
| 2022-07-05 | 2022-06-30 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | A - Grant | $0.00 | +7,397 | 16.1K | +85% | $0 | |
| D | 2022-05-18 | 2022-05-17 | TDOC | Teladoc Health, Inc. | Smith Mark Douglas | Dir | M - OptEx | — | +819 | 4,355 | +23% | — |
| 2021-12-06 | 2021-12-02 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | S - Sale | $121.30 | -417 | 4,419 | -9% | -$50.6K | |
| 2021-08-02 | 2021-07-29 | JAZZ | Jazz Pharmaceuticals plc | Smith Mark Douglas | Dir | A - Grant | $0.00 | +2,246 | 4,836 | +87% | $0 | |
| 2021-07-12 | 2021-07-08 | PHR | Phreesia, Inc. | Smith Mark Douglas | Dir | A - Grant | $0.00 | +2,605 | 8,715 | +43% | $0 |
Purchase Sale Sale after option exercise All abbreviations